Literature DB >> 8652367

Characterization of TGF-beta 1-binding proteins in human bone marrow stromal cells.

M M Robledo1, A Hidalgo, P Lastres, A G Arroyo, C Bernabeu, F Sánchez-Madrid, J Teixidó.   

Abstract

The proliferation and differentiation of haemopoietic progenitor cells is dependent on their close relation with bone marrow stromal cells, which constitute a source of cytokines as well as expressing receptors for both the cytokines and progenitor cell adhesion molecules necessary for regulated haemopoiesis. We have generated human bone marrow stromal cell cultures and analysed the TGF-beta 1 receptor components expressed by these cells. [125I]TGF-beta 1-affinity labelling experiments showed the involvement of type I and II receptors in the binding of TGF-beta 1, as demonstrated by specific immunoprecipitation of [125I]TGF-beta 1-receptor complexes. In addition, large TGF-beta 1-labelled complexes displaying an electrophoretic mobility similar to betaglycan were also observed in these experiments. Endoglin, another component of the TGF-beta receptor system, was detected by flow cytometry on the surface of cultured marrow stromal cells, and in the human bone marrow stromal cell line Str-5, and was immunoprecipitated from surface-iodinated cells. Endoglin on the stromal cells was able to bind TGF-beta 1, as demonstrated by specific immunoprecipitation of [125I]TGF-beta 1-endoglin complexes using anti-endoglin antibodies. The results presented provide evidence that bone marrow stromal cells are fully capable of responding to TGF-beta 1. Given the important role of TGF-beta as a regulator of the synthesis of cytokines and cytokine receptors, as well as cell adhesion molecules, these data indicate that the binding of TGF-beta 1 by stromal cells might represent an important step in the regulation of the proliferation and differentiation of haemopoietic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8652367     DOI: 10.1046/j.1365-2141.1996.d01-1698.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Expression of normal and truncated forms of human endoglin.

Authors:  U Raab; B Velasco; P Lastres; A Letamendía; C Calés; C Langa; E Tapia; J P López-Bote; E Páez; C Bernabéu
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

2.  Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development.

Authors:  N J Olsen; X Gu; W J Kovacs
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

3.  Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.

Authors:  Franck Lebrin; Marie-José Goumans; Leon Jonker; Rita L C Carvalho; Gudrun Valdimarsdottir; Midory Thorikay; Christine Mummery; Helen M Arthur; Peter ten Dijke
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

4.  Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants.

Authors:  Monique E De Paepe; Chintan Patel; Amy Tsai; Sravanthi Gundavarapu; Quanfu Mao
Journal:  Am J Respir Crit Care Med       Date:  2008-04-17       Impact factor: 21.405

5.  Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow.

Authors:  Martin A Vidal; Sandra O Robinson; Mandi J Lopez; Daniel B Paulsen; Olga Borkhsenious; Jill R Johnson; Rustin M Moore; Jeffrey M Gimble
Journal:  Vet Surg       Date:  2008-12       Impact factor: 1.495

Review 6.  Endoglin in the Spotlight to Treat Cancer.

Authors:  Teresa González Muñoz; Ana Teresa Amaral; Pilar Puerto-Camacho; Héctor Peinado; Enrique de Álava
Journal:  Int J Mol Sci       Date:  2021-03-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.